Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Angela B Mariotto"'
Autor:
Joana Bastos, Gonçalo Forjaz, Clara Castro, Alexandra Mayer, Anne-Michelle Noone, Huann-Sheng Chen, Angela B Mariotto
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Objectives This study aims to estimate the proportion of lung cancer cases and deaths attributable to tobacco smoking in Portugal in 2018, complemented by trends in incidence and mortality, by sex and region.Design Cancer cases for 1998–2011 and ca
Externí odkaz:
https://doaj.org/article/bd05ac9d0a44418e86df761c9d49f1e5
Autor:
Angela B Mariotto, Zhaohui Zou, Christopher J Johnson, Steve Scoppa, Hannah K Weir, Bin Huang
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0201034 (2018)
PURPOSE:Despite gains in life expectancy between 1992 to 2012, large disparities in life expectancy continue to exist in the United States between subgroups of the population. This study aimed to develop detailed life tables (LT), accounting for mort
Externí odkaz:
https://doaj.org/article/4ade7a6640e74f1ba76f80c8afbba905
Autor:
Yoon Duk Hong, Lindsey Enewold, Elad Sharon, Jeremy L. Warner, Amy J. Davidoff, Chris Zeruto, Angela B. Mariotto
Publikováno v:
Cancer Medicine, Vol 13, Iss 16, Pp n/a-n/a (2024)
Abstract Introduction In the last decade, melanoma treatment has improved significantly. However, data on population‐level treatment utilization and survival trends among older patients is limited. This study aimed to analyze trends in systemic ant
Externí odkaz:
https://doaj.org/article/24383c045dce4e1aaa3f30064e40ca01
Autor:
Laura Botta, Gemma Gatta, Annalisa Trama, Alice Bernasconi, Elad Sharon, Riccardo Capocaccia, Angela B. Mariotto, the RARECAREnet working group
Publikováno v:
Cancer Medicine, Vol 9, Iss 15, Pp 5632-5642 (2020)
Abstract Geographical variability of cancer burden was almost exclusively estimated for common cancers. Since rare cancers (RC) have become an area of priority for basic and clinical research and public health organizations, this paper provides, usin
Externí odkaz:
https://doaj.org/article/ed44ba51acb349bc90f90da0633e346b
Autor:
Nadia Howlader, Elad Sharon, Manami Bhattacharya, Lori A. Ehrlich, Nicholas C. Richardson, Nicole J. Gormley, R. Angelo de Claro, Amy E. Wood, Angela B. Mariotto, Kathleen A. Cronin
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. :OF1-OF4
Introduction: Molecularly targeted therapies such as tyrosine kinase inhibitors (TKI) are effective treatments for B-cell receptor (BCR)-ABL–bearing leukemias. We evaluated the impact of TKIs on historical chronic myeloid leukemia (CML) mortality t
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:659-665
Background: Metastatic prostate cancer (MPC) includes metastases detected at diagnosis (de novo) and those occurring after diagnosis with early-stage disease (recurrent). Cancer registries collect data only on de novo MPC, providing a partial picture
Autor:
Angela B Mariotto, Eric J Feuer, Nadia Howlader, Huann-Sheng Chen, Serban Negoita, Kathy Cronin
Publikováno v:
JNCI: Journal of the National Cancer Institute.
The significant deficit in cancer diagnoses in 2020 due to COVID-19 pandemic disruptions in health care, can pose challenges in the estimation and interpretation of long-term cancer trends. Using SEER (2000-2020) data, we demonstrate that inclusion o
Autor:
Kathleen A. Cronin, Angela B. Mariotto, Amy E. Wood, R. Angelo de Claro, Nicole J. Gormley, Nicholas C. Richardson, Lori A. Ehrlich, Manami Bhattacharya, Elad Sharon, Nadia Howlader
Supplementary Figure 1: Trends in Mortality by Leukemia Subtypes and Race Ethnicity. Total US 1992-2018. Results are shown for mortality trends for CML (panel A), ALL (panel B), and CLL (panel C), 1992-2018. For each panel, we show age-adjusted morta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dbb286b4d5ecabda426756d34cb6f14
https://doi.org/10.1158/1055-9965.22743779.v1
https://doi.org/10.1158/1055-9965.22743779.v1
Autor:
Kathleen A. Cronin, Angela B. Mariotto, Amy E. Wood, R. Angelo de Claro, Nicole J. Gormley, Nicholas C. Richardson, Lori A. Ehrlich, Manami Bhattacharya, Elad Sharon, Nadia Howlader
Introduction:Molecularly targeted therapies such as tyrosine kinase inhibitors (TKI) are effective treatments for B-cell receptor (BCR)-ABL–bearing leukemias. We evaluated the impact of TKIs on historical chronic myeloid leukemia (CML) mortality tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1608fc95c4bc943532fef93efcac9e5
https://doi.org/10.1158/1055-9965.c.6628385
https://doi.org/10.1158/1055-9965.c.6628385
Supplementary Figure S2: Prevalence over time for all races, assuming better recurrent survival. Solid black linerepresents estimated number of new metastatic prostate cancer (MPC) cases; dashed blue line representsobserved number of prostate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe4f97c562d068662f50086111fd4a8
https://doi.org/10.1158/1055-9965.22725489
https://doi.org/10.1158/1055-9965.22725489